SEERKIT

Hypothyroid Diagnosis

Health Tech & Life Sciences
Non Active, Sep 2022 ceased to operate
Pre-Funding Founded 2022
Total raised
Stage
Pre-Funding
Founded
2022
Headcount
1-10
HQ
Sector
Health Tech & Life Sciences

About

SEERKIT is focused on improving the diagnosis and treatment of hypothyroid disorder. The company's core algorithm is based on a model that is constantly updated with physician and patient data, the latest research, and community feedback to help each patient navigate their specific journey.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is SEERKIT's primary focus?
SEERKIT is focused on improving the diagnosis and treatment of hypothyroid disorder.
When was SEERKIT founded?
SEERKIT was founded in January 2022.
What is the operational status of SEERKIT?
SEERKIT is currently inactive, having ceased operations in September 2022.
What technology does SEERKIT utilize in its core algorithm?
SEERKIT's core algorithm is based on Artificial Intelligence.
Who is the founder of SEERKIT?
Maydan Wienreb is the founder of SEERKIT.
What is SEERKIT's current funding stage?
SEERKIT is in the Pre-Funding stage.
What is the estimated employee count for SEERKIT?
SEERKIT has an estimated employee count of 1-10.
What business models does SEERKIT employ?
SEERKIT uses B2B2C and B2B business models.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportBusiness SoftwareIT, R&D & Data SolutionsData Architecture
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatientsLaboratoriesProviders
Business model
B2B2CB2B

Highlights

Verified

Tags

algorithmslaboratoriesartificial-intelligencedecision-supporttreatmentsdiagnosticschronic-diseasedigital-healthcaredoctorspatients